Int J Stomatol

Int J Stomatol ›› 2021, Vol. 48 ›› Issue (2): 147-155.doi: 10.7518/gjkq.2021020

• Oral Medicine • Previous Articles     Next Articles

Research progress on the problems of dental implant treatment in patients with common oral mucosal disease

Feng Lu1,2(),Meng Wenxia1()   

  1. 1. Dept. of Oral Medicine, Stomatological Hospital, Southern Medical University, Guangzhou 510008, China
    2. Dept. of Stomatology, Beihai People ,s Hospital, Beihai 536000, China
  • Received:2020-06-15 Revised:2020-11-10 Online:2021-03-01 Published:2021-03-17
  • Contact: Wenxia Meng E-mail:350343180@qq.com;mengwx2008@foxmail.com
  • Supported by:
    National Natural Science Foundation of China(81500850)

RichHTML

139

PDF (PC)

815

Abstract:

Given advancements in prosthodontics as well as increasing demands for a high quality of life, dental implants for patients with dentition defects and suffering from oral mucosal diseases (OMDs) have received increased attention. However, whether implant treatment is feasible and effective for these patients, as well as the related guidelines, is unknown. This paper reviews the implant-prosthetic rehabilitation progress of patients with common OMDs, such as oral lichen planus, autoimmune bullous disease, and Sjögren,s syndrome. The results of this work serve as a reference for future research on stomatology.

Key words: oral lichen planus, autoimmune bullous disease, Sjögren's syndrome, dental implant

CLC Number: 

  • R781.5

TrendMD: 

Tab 1

Evaluation of implant-prosthetic rehabilitation in patients with common oral mucousal disease"

疾病 系统分析 病例报道例数/例 随访时间 可能的风险因素 风险因素的应对措施 总结
OLP[8] 成功率
98%		 100 平均
44.6个月		 1）糖皮质激素;
2）其他免疫抑制剂,如他克莫司、环孢素的应用		 1）糖皮质激素的使用可能导致骨质疏松,但骨质疏松对种植体长期骨结合的维持无影响;
2）其他免疫抑制剂对骨结合的影响未明确		 疾病控制,口内无糜烂溃疡时可行种植修复
LE[21] — 1 24个月 1）糖皮质激素的应用;
2）羟氯喹的应用;
3）口腔感染;
4）全身器官损害		 1）糖皮质激素的使用可能导致骨质疏松,但骨质疏松对种植体长期骨结合的维持无影响;
2）羟氯喹对骨结合的影响未明确;
3）注意预防口腔念珠菌的感染,教会患者自我保持口腔卫生;
4）术前谨慎评估全身损害,必要时请内科医生会诊		 疾病控制,口内无糜烂溃疡时,可考虑行种植修复
寻常型天疱疮[27] — 1 32个月 糖皮质激素的应用 糖皮质激素的使用可能导致骨质疏松,但骨质疏松对种植体长期骨结合的维持无影响 疾病控制,口内无糜烂、溃疡、起疱时,可考虑行种植修复
黏膜良性类
天疱疮[27]		 — 1 15年 糖皮质激素的应用 糖皮质激素的使用可能导致骨质疏松,但骨质疏松对种植体长期骨结合的维持无影响 疾病控制,口内无糜烂、溃疡、起疱时,可考虑行种植修复
SS[31] 失败率
4.1%		 186 平均
72.5个月		 1）唾液分泌功能下降;
2）糖皮质激素的应用;
3）其他药物的应用;
4）继发性SS伴糖尿病		 1）SS唾液分泌功能下降,需对症治疗,教会患者保持良好的口腔卫生;
2）糖皮质激素的使用可能导致骨质疏松,但骨质疏松对种植体长期骨结合的维持无影响;
3）甲氨喋呤的应用增加骨折风险,应谨慎对待;
4）伴全身性疾病的SS患者种植修复需谨慎对待		 推荐适当条件下在SS患者中行种植修复,但是需要重视术前全身状态的评估,教会患者自我口腔维护,定期 随访
AIDS[47] 成功率
94.76%		 169 平均
47.9个月		 1）CD4淋巴细胞百分数≤20%,种植体放置于上颌,吸烟及抗逆转录病毒治疗4项因素;
2）骨密度低,骨质疏松风险高		 1）术前全身状态评估,CD4淋巴细胞的百分数>20%;
2）口腔内黏膜完整,无黏膜病损;
3）术前、术后抗生素应用控制感染风险必不可少		 全身条件许可,口腔黏膜完整,感染风险可控的情况下,可以行种植 修复

Fig 1

A diagram of the diagnosis and treatment of implant-prosthetic rehabilitation of patients with oral mucousal disease"

[1] Diz P, Scully C, Sanz M. Dental implants in the medically compromised patient[J]. J Dent, 2013,41(3):195-206.
pmid: 23313715
[2] Liu GX, Xie Q, Zhou CJ, et al. The possible roles of OPN-regulated CEACAM1 expression in promo-ting the survival of activated T cells and the apoptosis of oral keratinocytes in oral lichen planus patients[J]. J Clin Immunol, 2011,31(5):827-839.
doi: 10.1007/s10875-011-9552-4 pmid: 21671129
[3] 陈宇雄, 黄元瑾. 种植体周围炎中IL-1β、TNF-α、NF-κB信号通路研究进展[J]. 口腔疾病防治, 2018,26(10):673-676.
Chen YX, Huang YJ. Study progress of the correla-tion between peri-implantitis, IL-1β, TNF-α and NF-κB signal transduction[J]. J Dent Prev Treat, 2018,26(10):673-676.
[4] Romano F, Arduino PG, Maggiora M, et al. Effect of a structured plaque control on MMP-1 and MMP-9 crevicular levels in patients with desquamative gingivitis associated with oral lichen planus[J]. Clin Oral Investig, 2019,23(6):2651-2658.
[5] Chapple ILC, Mealey BL, Van Dyke TE, et al. Perio-dontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions[J]. J Periodontol, 2018,89(Suppl 1):S74-S84.
[6] Hernández G, Lopez-Pintor RM, Arriba L, et al. Implant treatment in patients with oral lichen planus: a prospective-controlled study[J]. Clin Oral Implants Res, 2012,23(6):726-732.
doi: 10.1111/j.1600-0501.2011.02192.x pmid: 21492237
[7] Petruzzi M, De Benedittis M, Cortelazzi R, et al. Implant rehabilitation in patients with oral lichen planus: an overview[J]. Clin Oral Investig, 2012,16(5):1347-1352.
doi: 10.1007/s00784-012-0695-3 pmid: 22382447
[8] Strietzel FP, Schmidt-Westhausen AM, Neumann K, et al. Implants in patients with oral manifestations of autoimmune or muco-cutaneous diseases-a systematic review[J]. Med Oral Patol Oral Cir Bucal, 2019,24(2):e217-e230.
doi: 10.4317/medoral.22786 pmid: 30818315
[9] Esposito M, Thomsen P, Ericson LE, et al. Histopathologic observations on late oral implant failures[J]. Clin Implant Dent Relat Res, 2000,2(1):18-32.
doi: 10.1111/j.1708-8208.2000.tb00103.x pmid: 11359271
[10] 陶小安, 程斌. 口腔扁平苔藓治疗现状分析[J]. 口腔疾病防治, 2018,26(3):143-150.
Tao XA, Cheng B. The present situation in treat-ment for oral lichen planus[J]. J Dent Prev Treat, 2018,26(3):143-150.
[11] Buser D, Martin W, Belser UC. Optimizing esthe-tics for implant restorations in the anterior maxilla: anatomic and surgical considerations[J]. Int J Oral Maxillofac Implants, 2004,19(Suppl):43-61.
[12] Mori H, Manabe M, Kurachi Y, et al. Osseointegration of dental implants in rabbit bone with low mi-neral density[J]. J Oral Maxillofac Surg, 1997,55(4):351-361.
doi: 10.1016/s0278-2391(97)90124-5 pmid: 9120698
[13] Giro G, Chambrone L, Goldstein A, et al. Impact of osteoporosis in dental implants: a systematic review[J]. World J Orthop, 2015,6(2):311-315.
pmid: 25793172
[14] Khamis AK, Aboushelib MN, Helal MH. Clinical management protocol for dental implants inserted in patients with active lichen planus. Part Ⅱ 4-year follow-up[J]. J Prosthodont, 2019,28(5):519-525.
doi: 10.1111/jopr.12993 pmid: 30357978
[15] Paredes V, López-Pintor RM, Torres J, et al. Implant treatment in pharmacologically immunosuppressed liver transplant patients: a prospective-controlled study[J]. Clin Oral Impl Res, 2018,29(1):28-35.
[16] de Molon RS, Sakakura CE, Faeda RS, et al. Effect of the long-term administration of Cyclosporine A on bone healing around osseointegrated titanium implants: a histomorphometric study in the rabbit tibia[J]. Microsc Res Tech, 2017,80(9):1000-1008.
doi: 10.1002/jemt.22894 pmid: 28544667
[17] Agha-Hosseini F, Rohani B. Evaluation of the effects of dental implants on oral lesions[J]. J Contemp Dent Pract, 2015,16(5):400-406.
doi: 10.5005/jp-journals-10024-1697 pmid: 26162261
[18] Shearston K, Fateh B, Tai SX, et al. Oral lichenoid dysplasia and not oral lichen planus undergoes malignant transformation at high rates[J]. J Oral Pathol Med, 2019,48(7):538-545.
doi: 10.1111/jop.12904 pmid: 31172588
[19] Sicilia A, Cuesta S, Coma G, et al. Titanium allergy in dental implant patients: a clinical study on 1 500 consecutive patients[J]. Clin Oral Implant Res, 2008,19(8):823-835.
[20] Javed F, Al-Hezaimi K, Almas K, et al. Is titanium sensitivity associated with allergic reactions in patients with dental implants? A systematic review[J]. Clin Implant Dent Relat Res, 2013,15(1):47-52.
doi: 10.1111/j.1708-8208.2010.00330.x pmid: 21414135
[21] du Preez LA, Bütow KW, Swart TJ. Implant failure due to titanium hypersensitivity/allergy? Report of a case[J]. SADJ, 2007,62(1):22, 24-25.
[22] Ergun S, Katz J, Cifter ED, et al. Implant-supported oral rehabilitation of a patient with systemic lupus erythematosus: case report and review of the literature[J]. Quintessence Int, 2010,41(10):863-867.
pmid: 20927423
[23] Rhodus NL, Johnson DK. The prevalence of oral manifestations of systemic lupus erythematosus[J]. Quintessence Int, 1990,21(6):461-465.
pmid: 2243950
[24] Takahama A Jr, de Lima HG, Ito FA, et al. Epstein-Barr virus-positive mucocutaneous ulcer mimic-king peri-implantitis in a patient with systemic lupus erythematosus[J]. J Oral Maxillofac Surg, 2019,77(5):977-984.
doi: 10.1016/j.joms.2018.12.035 pmid: 30710499
[25] Rashid H, Lamberts A, Diercks GFH, et al. Oral lesions in autoimmune bullous diseases: an overview of clinical characteristics and diagnostic algorithm[J]. Am J Clin Dermatol, 2019,20(6):847-861.
doi: 10.1007/s40257-019-00461-7 pmid: 31313078
[26] Buonavoglia A, Leone P, Dammacco R, et al. Pemphigus and mucous membrane pemphigoid: an update from diagnosis to therapy[J]. Autoimmun Rev, 2019,18(4):349-358.
pmid: 30738958
[27] Arduino PG, Broccoletti R, Carbone M, et al. Describing the gingival involvement in a sample of 182 Italian predominantly oral mucous membrane pemphigoid patients: a retrospective series[J]. Med Oral Patol Oral Cir Bucal, 2017,22(2):e149-e152.
doi: 10.4317/medoral.21431 pmid: 28160581
[28] Altin N, Ergun S, Katz J, et al. Implant-supported oral rehabilitation of a patient with pemphigus vulgaris: a clinical report[J]. J Prosthodont, 2013,22(7):581-586.
pmid: 23552022
[29] Megarbane JM, Freiha C, Mokbel N. Oral rehabilitation of a severe periodontally involved patient with mucous membrane pemphigoid: a 15-year follow-up case report[J]. Int J Periodontics Restorative Dent, 2017,37(5):743-748.
pmid: 28355312
[30] Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome[J]. Arch Intern Med, 2004,164(12):1275-1284.
doi: 10.1001/archinte.164.12.1275 pmid: 15226160
[31] Proctor DM, Fukuyama JA, Loomer PM, et al. A spatial gradient of bacterial diversity in the human oral cavity shaped by salivary flow[J]. Nat Commun, 2018,9(1):681.
pmid: 29445174
[32] Chrcanovic BR, Kisch J, Wennerberg A. Dental implants in patients with Sjögren,s syndrome: a case series and a systematic review[J]. Int J Oral Maxillofac Surg, 2019,48(9):1250-1259.
doi: 10.1016/j.ijom.2019.02.005 pmid: 30827571
[33] Albrecht K, Callhoff J, Westhoff G, et al. The prevalence of dental implants and related factors in patients with Sjögren syndrome: results from a cohort study[J]. J Rheumatol, 2016,43(7):1380-1385.
doi: 10.3899/jrheum.151167 pmid: 27134257
[34] Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology[J]. J Clin Periodontol, 2015,42(Suppl 16):S158-S171.
[35] Korfage A, Raghoebar GM, Arends S, et al. Dental implants in patients with Sjögren,s syndrome[J]. Clin Implant Dent Relat Res, 2016,18(5):937-945.
doi: 10.1111/cid.12376 pmid: 26399938
[36] Oczakir C, Balmer S, Mericske-Stern R. Implant-prosthodontic treatment for special care patients: a case series study[J]. Int J Prosthodont, 2005,18(5):383-389.
pmid: 16220802
[37] Almeida D, Vianna K, Arriaga P, et al. Dental implants in Sjögren,s syndrome patients: a systematic review[J]. PLoS One, 2017,12(12):e0189507.
doi: 10.1371/journal.pone.0189507 pmid: 29240793
[38] Gandía M, Morales-Espinoza EM, Martín-González RM, et al. Factors influencing dry mouth in patients with primary Sjögren syndrome: usefulness of the ESSPRI index[J]. Oral Health Dent Manag, 2014,13(2):402-407.
pmid: 24984655
[39] Chrcanovic BR, Albrektsson T, Wennerberg A. Diabetes and oral implant failure: a systematic review[J]. J Dent Res, 2014,93(9):859-867.
pmid: 24928096
[40] de Mendonça Invernici M, Finger Stadler A, Vale Nicolau G, et al. Management of Sjogren,s syndro-me patient: a case report of prosthetic rehabilitation with 6-year follow-up[J]. Case Rep Dent, 2014,2014:761251.
doi: 10.1155/2014/761251 pmid: 25478245
[41] Bornstein MM, Cionca N, Mombelli A. Systemic conditions and treatments as risks for implant therapy[J]. Int J Oral Maxillofac Implants, 2009,24(Suppl):12-27.
[42] Andreasen CM, Ding M, Andersen TL, et al. Effects of substitute coated with hyaluronic acid or poly-lactic acid on implant fixation: experimental study in ovariectomized and glucocorticoid-treated sheep[J]. J Tissue Eng Regen Med, 2018,12(2):e1122-e1130.
doi: 10.1002/term.2447 pmid: 28485126
[43] Mirouse A, Seror R, Vicaut E, et al. Arthritis in primary Sjögren,s syndrome: characteristics, outcome and treatment from French multicenter retrospective study[J]. Autoimmun Rev, 2019,18(1):9-14.
doi: 10.1016/j.autrev.2018.06.015 pmid: 30408585
[44] Ozen G, Pedro S, Wolfe F, et al. Medications asso-ciated with fracture risk in patients with rheumatoid arthritis[J]. Ann Rheum Dis, 2019,78(8):1041-1047.
doi: 10.1136/annrheumdis-2019-215328 pmid: 31092411
[45] Tavakoli M, Yaghini J, Abed AM, et al. Evaluation of effect of low-dose methotrexate on osseointegration of implants: a biomechanical study on dogs[J]. Open Dent J, 2018,12:546-554.
pmid: 30197693
[46] Aškinytė D, Matulionytė R, Rimkevičius A. Oral manifestations of HIV disease: a review[J]. Stomatologija, 2015,17(1):21-28.
pmid: 26183854
[47] Rajnay ZW, Hochstetter RL. Immediate placement of an endosseous root-form implant in an HIV-positive patient: report of a case[J]. J Periodontol, 1998,69(10):1167-1171.
doi: 10.1902/jop.1998.69.10.1167 pmid: 9802718
[48] Lemos CAA, Verri FR, Cruz RS, et al. Survival of dental implants placed in HIV-positive patients: a systematic review[J]. Int J Oral Maxillofac Surg, 2018,47(10):1336-1342.
pmid: 29555240
[49] Sabbah A, Hicks J, MacNeill B, et al. A retrospective analysis of dental implant survival in HIV patients[J]. J Clin Periodontol, 2019,46(3):363-372.
doi: 10.1111/jcpe.2019.46.issue-3
[50] Compston J. HIV infection and bone disease[J]. J Intern Med, 2016,280(4):350-358.
pmid: 27272530
[51] Biver E, Calmy A, Aubry-Rozier B, et al. Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis[J]. Osteoporos Int, 2019,30(5):1125-1135.
doi: 10.1007/s00198-018-4794-0 pmid: 30603840
[52] Vikulina T, Fan X, Yamaguchi M, et al. Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats[J]. Proc Natl Acad Sci U S A, 2010,107(31):13848-13853.
doi: 10.1073/pnas.1003020107 pmid: 20643942
[53] Chokuda E, Reynolds C, Das S. Association of low vitamin D with complications of HIV and AIDS: a literature review[J]. Infect Disord Drug Targets, 2020,20(2):122-142.
doi: 10.2174/1871526519666181221122731
[54] Manion M, Hullsiek KH, Wilson EMP, et al. Vitamin D deficiency is associated with IL-6 levels and monocyte activation in HIV-infected persons[J]. PLoS One, 2017,12(5):e0175517.
doi: 10.1371/journal.pone.0175517
[55] Oliveira MA, Gallottini M, Pallos D, et al. The success of endosseous implants in human immunodeficiency virus-positive patients receiving antiretroviral therapy: a pilot study[J]. J Am Dent Assoc, 2011,142(9):1010-1016.
[56] Dalla Grana E, Rigo F, Lanzafame M, et al. Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and hepatitis B and C-infected patients treated with ART[J]. Front Endocrinol (Lausanne), 2019,10:302.
[57] Hwang D, Wang HL. Medical contraindications to implant therapy: part Ⅱ: relative contraindications[J]. Implant Dent, 2007,16(1):13-23.
doi: 10.1097/ID.0b013e31803276c8 pmid: 17356368
[58] Castellanos-Cosano L, Núñez-Vázquez RJ, Segura-Egea JJ, et al. Protocol for oral implant rehabilitation in a hemophilic HIV-positive patient with type C hepatitis[J]. Implant Dent, 2014,23(5):622-625.
doi: 10.1097/ID.0000000000000145 pmid: 25238270
[59] Harrison WJ, Lewis CP, Lavy CB. Wound healing after implant surgery in HIV-positive patients[J]. J Bone Joint Surg Br, 2002,84(6):802-806.
doi: 10.1302/0301-620x.84b6.12641 pmid: 12211668
[60] Gherlone EF, Capparé P, Tecco S, et al. Implant prosthetic rehabilitation in controlled HIV-positive patients: a prospective longitudinal study with 1-year follow-up[J]. Clin Implant Dent Relat Res, 2016,18(4):725-734.
pmid: 25955953
[1] Li Ran,Hu Yue,Zhang Ning,Gao Ruifang,Wang Xiangyu,Ge Xuejun. The correlation study between single nucleotide polymorphisms of Toll-like receptor and interleukin-17 and oral lichen planus [J]. Int J Stomatol, 2024, 51(1): 45-51.
[2] Han Chong,He Dongning,Yu Feiyan,Wu Dongchao. Research progress on the mechanism and treatment of pain after oral implants [J]. Int J Stomatol, 2024, 51(1): 99-106.
[3] Wang Sujie,Tan Qin,Wei Yuan,Wang Jie,Fan Jie,Yue Erli.. Correlation analysis of serum angiopoietin-2 level with forkhead/winged helix transcription factor p3 regulatory T cells and disease activity in patients with oral lichen planus [J]. Int J Stomatol, 2023, 50(6): 674-678.
[4] Liao Honglin,Fang Zhonghan,Zhang Yanyan,Liu Fei,Shen Jiefei.. Diagnosis and treatment of post-traumatic trigeminal neuropathic pain after dental implantation [J]. Int J Stomatol, 2023, 50(6): 729-738.
[5] Gong Jiaming,Zhao Ruimin,Pan Hongwei,Lang Xin,Yu Zhanhai,Li Jianxue. Meta-analysis of dynamic navigation versus static navigation in the accuracy of implant surgery [J]. Int J Stomatol, 2023, 50(5): 538-551.
[6] Zhu Keshi,Liao Anqi,Yu Youcheng.. Research progress on the application of machine learning in dental implantology [J]. Int J Stomatol, 2023, 50(4): 491-498.
[7] He Jing,Hu Mingjia,Xiao Ning,Li Jia,Sun Wanxin,Ling Lü,Liu Fan. Investigation on the degree of psychological distress and its influencing factors in patients with oral lichen planus [J]. Int J Stomatol, 2023, 50(3): 308-313.
[8] Lu Qian,Xia Haibin,Wang Min.. Research progress on implantoplasty in the treatment of peri-implantitis [J]. Int J Stomatol, 2023, 50(2): 152-158.
[9] Man Yi, Huang Dingming. Combined treatment strategy of oral implantology and endodontics microsurgery: clinical protocol and practical cases (part 2) [J]. Int J Stomatol, 2022, 49(6): 621-632.
[10] Zhang Shenyi,Wang Xiangjian,Shi Liran,Shi Jiahong,Wang Yuhong,Zhou Hongmei. Oral beta-carotene in the treatment of non-erosive oral lichen planus: a randomized controlled trial [J]. Int J Stomatol, 2022, 49(6): 633-640.
[11] Man Yi, Huang Dingming. Combined treatment strategy of oral implantology and endodontic microsurgery for bone augmentation and en-dodontic diseases in aesthetic area (part 1): application basis and indications [J]. Int J Stomatol, 2022, 49(5): 497-505.
[12] Chen Siting,Zhong Xiong,Meng Wenxia.. Research progress on Nod-like receptor protein 3 inflammasome in oral mucosal diseases [J]. Int J Stomatol, 2022, 49(4): 471-475.
[13] Wang Yue,Wen Bing,Deng Mengting,Li Jianping. Research advances of low-level laser therapy on peri-implant tissue healing [J]. Int J Stomatol, 2021, 48(6): 725-730.
[14] Zhu Xuanzhi,Zhao Lei. Research progress on the relationship between hypothyroidism and periodontitis [J]. Int J Stomatol, 2021, 48(4): 380-384.
[15] Liu Siyu,Li Xin,Xu Xiaoyu,Sun Yinyin,Pan Yingxiao,Wang Sainan,Lu Shulai. Research advances in the relationship between oral lichen planus and cardiovascular diseases [J]. Int J Stomatol, 2021, 48(2): 141-146.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[7] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[8] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[9] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[10] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .